Abstract:OBJECTIVE:To explore the expression and clinical significance of chemokine CXCL10 and CXCR3 in hepatocellular carcinoma (HCC). METHODS:The expression and prognostic of CXCL10 and CXCR3 in HCC tumor tissues and non-tumor tissues were analyzed in two different publicly available databases the Cancer Genome Atlas (TCGA) and Liver Cancer Institute (LCI). In addition, quantitative real-time PCR (qPCR) was used to detect the mRNA expression of CXCL10 and CXCR3 in 45 HCC clinical samples with HBV infection background. Pearson correlation and Spearman rank correlation were used to determine the correlation between the expression level of CXCL10 and CXCR3 in tumor and non-tumor tissues. RESULTS:In TCGA database, the expression of CXCL10 in HCC tumor tissues was significantly higher than that in non-tumor tissues (nonpaired samples: 3.379±2.081 vs. 2.213±2.274, P<0.001; paired samples: 3.159±2.267 vs. 2.213±2.274, P=0.018). Similarly in LCI datebase (7.625±1.683 vs. 7.287±1.328, P=0.009). And higher CXCL10 expression was significantly associated with a better prognosis in the patients with HCC both in TCGA and LCI database (P=0.107, P=0.002). In TCGA database, the expression of CXCR3 in HCC tumor tissues was significantly higher than that in non-tumor tissues (nonpaired samples: -0.906±1.697 vs. -1.978±1.629, P<0.001; paired samples: -1.329±1.732 vs. -1.978±1.629, P=0.037), while lower in LCI database (3.989±0.339 vs. 4.074±0.309, P=0.003). In both databases, higher CXCR3 expression was significantly associated with a better prognosis in the HCC patients (P=0.004, P=0.014). Furthermore, in TCGA database, the expression level of CXCL10 and CXCR3 was positively correlated both in HCC tumor tissues and matched non-tumor tissues (r=0.584, P<0.001; r=0.776, P<0.001). The qPCR assay showed that the expression of CXCL10 in HBV-related HCC tumor tissues was significantly higher than those in normal liver tissues [0.479(0.223, 1.094) vs. 0.131(0.106, 0.159), P=0.010], and the expression in HBV-related non-tumor tissues was also significantly higher than those in normal liver tissues [0.484(0.241, 0.846) vs. 0.131(0.106, 0.159), P<0.001]. The same was true as CXCR3 [0.011(0.006, 0.019) vs. 0.002(0.001, 0.004), P=0.004; 0.016(0.011, 0.021) vs. 0.002(0.001, 0.004), P<0.001]. However there was no significant difference of CXCL10 and CXCR3 between tumor tissues and matched non-tumor tissues (P=1.000, P=0.374). CONCLUSION:Expression of CXCL10 was up-regulated in HCC tissues, expression of CXCR3 was down-regulated in HBV-related HCC tissues, and the higher expression of both genes was correlated with better overall survival in HCC patients.

Expression and Clinical Significance of Beclin 1 in Patients with Hepatocellular Carcinoma

BC047440 Overexpression is a Risk Factor for Tumor Invasion and Poor Prognosis in Hepatocellular Carcinoma.

Expression of Glucose Transporter-1, Hypoxia Inducible Factor-1Α and Beclin-1 in Head and Neck Cancer and Their Implication.

Expression of Beclin-1 in non-small cell lung cancer and its clinical significance

Expression and clinical significance of GS,E-cadherin and β-catenin in hepatocellular carcinoma

Expression of SRF, E-cadherin and β-catenin in hepatocellular carcinoma and its clinical significances

[Expression and Clinical Significance of Beclin1 and PTEN in Endometrial Carcinoma].

Beclin 1 Deficiency Correlated with Lymph Node Metastasis, Predicts a Distinct Outcome in Intrahepatic and Extrahepatic Cholangiocarcinoma.

The role of Beclin1 in the occurrence and development of lung adenocarcinoma and its effect onprognosis

Significance of Expression of Thrombospondin- 1 and Receptor- CD36 in Hepatocellular Carcinoma

Expression and clinical significance of CD117,C-erbB-2 and EGFR in primary hepatocellular carcinoma

The Role of Beclin-1 Expression in Patients with Gastric Cancer: a Meta-Analysis

Expression and significance of CCR1 chemokine receptor in human hepatocellular carcinoma

Prognostic significance of Beclin 1-dependent apoptotic activity in hepatocellular carcinoma.

Expression and Clinical Significance of CD146 and VEGF in Hepatocellular Carcinoma

Biological Significance of the Expression of B-myb in Hepatocellular Carcinoma and the Correlation with Cyclin D1

Expression of Caveolin-1 Gene in Hepatitis B-related Hepatocellular Carcinoma and the Clinical Significance Thereof

The Expression of CD88 in Hepatocellular Carcinoma and Its Clinical Significance

[Expression and clinical significance of chemokine CXCL10 and its receptor CXCR3 in hepatocellular carcinoma].

The Roles of Beclin 1 Expression in Gastric Cancer: A Marker for Carcinogenesis, Aggressive Behaviors and Favorable Prognosis, and a Target of Gene Therapy

The Expression and Significance of Tumor Necrosis Factor Receptor 1 in Human Hepatocellular Carcinoma